GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **676 - 700** of **4050** in total

« First

‹ Prev

…

24

25

26

27

28

29

30

31

32

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgM	Patient 2	3	mild	G12200GB	44
IgG	Patient 3	-180	mild	G00054MO	44
IgG	Patient 3	-180	mild	G02670IJ	44
IgG	Patient 3	-180	mild	G09609EN	44
IgG	Patient 3	-180	mild	G15209MJ	44
IgG	Patient 3	-180	mild	G22768VO	44
IgG	Patient 3	-180	mild	G57449OF	44
IgG	Patient 3	-180	mild	G58969RU	44
IgG	Patient 3	-180	mild	G72424VO	44
IgG	Patient 3	11	mild	G00065MO	44
IgG	Patient 3	11	mild	G19868AX	44
IgG	Patient 3	11	mild	G38488WF	44
IgG	Patient 3	11	mild	G40696TO	44
IgG	Patient 3	11	mild	G53168IY	44
IgG	Patient 3	11	mild	G82942ZJ	44
IgG	Patient 3	4	mild	G09609EN	44
IgG	Patient 3	4	mild	G18057VI	44
IgG	Patient 3	4	mild	G25473LQ	44
IgG	Patient 3	4	mild	G28868ZC	44
IgG	Patient 1	10	moderate	G32473MI	45
IgG	Patient 1	10	moderate	G68703KI	45
IgG	Patient 1	22	moderate	G09482NW	45
IgG	Patient 1	22	moderate	G65889KE	45
IgG	Patient 1	6	moderate	G21290RB	45
IgM	Patient 1	10	moderate	G00048MO	45